Results

Total Results: 1,220 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

61. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
    March 01, 2011 - Key Question 3: Adverse Events and Side Effects This Key Question was addressed by 107 studies. … Other adverse events. … We found reports of four types of adverse events that were not addressed in our previous evidence report … Moderate Metformin was associated with more frequent GI adverse events than were DPP-4 inhibitors. … (continued) Moderate Metformin monotherapy was associated with more frequent GI adverse events than

62. Kidney-Stone-Prevention Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - specific adverse events. … The trial reported no other adverse events data. … Other adverse events reporting was poor. … The study did not report results for adverse events. … conditions as well as any adverse events, serious adverse events, adverse events causing withdrawal

63. Treatments for Schizophrenia in Adults: A Systematic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/executive-summary-2017-schizophrenia-adult.pdf
    January 01, 2017 - events (frequency of any adverse events reported in trials) • Withdrawals due to adverse events, time … • Significant (major) adverse events Key Question 2: • Overall adverse events (frequency of any adverse … events reported int rials) • Withdrawals due to adverse events, time to withdrawal due to adverse events … events, and withdrawal from treatment due to adverse events. … events and withdrawal due to adverse events.

64. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
    September 01, 2011 - Adverse events 22 Low 1 fair trial: no significant differences in ECT + rTMS specific adverse events … VNS vs. sham Adverse events 235 Low 1 fair trial: Some differences in specific adverse events reported … Safety, Adverse Events, and Adherence (KQ 4) Direct evidence. … Specific adverse events. … More careful and consistent assessment of adverse events is required.

65. Breast-Biopsy-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
    September 01, 2014 - • What factors associated with the patient and her breast abnormality influence the adverse events of … Events and Additional Surgeries After Biopsy In general, adverse events were reported inconsistently … Core needle biopsy was only infrequently associated with serious adverse events. … adverse events) compared to core needle biopsy. … Our assessment of the strength of evidence for adverse events is summarized in Table H.

66. Cancer-Anemia-Update Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - Transfusion carries a very low risk of infection and other adverse events, including transfusion reactions … (For example, adverse events that could be definitively attributed to transfusions were not reported … Thromboembolic Events ESA treatment increased the risk of thromboembolic events (overall strength of … There were fewer thromboembolic and on-study mortality adverse events when ESA treatment was delayed … Whether there are subgroups at higher and lower risk of adverse events and mortality is unclear.

67. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - b: Are there any differences in safety, adverse events, or adherence between immediate release and … Also, adverse events may occur at any point after the treatment is received. … Also, adverse events may occur at any point after the treatment is received. IV. … events Withdrawals because of adverse events Discontinuation rates because of adverse events … Serious adverse events Specific adverse events or withdrawals because of specific adverse events

68. Cer-242-Radiation-Therapy-Brain-Metastases-Evidence-Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
    June 01, 2021 - • We did not detect consistent differences in serious adverse events, number of reported adverse … events, radiation necrosis, headaches, fatigue and seizures across interventions. … events, adverse events, radiation necrosis, headaches, fatigue, seizure, vomiting. … Adverse Events We found no difference in serious adverse events when comparing WBRT plus SRS with … Events Effects of Patient Characteristics Strengths and Limitations Implications and Conclusions

69. AHRQ Evidence-Based Practice Center (EPC) Program Research Gaps Summary: Pain Management (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
    January 01, 2023 - Serious adverse events are more common in patients who received lasmiditan than placebo. … Evidence is insufficient to draw conclusions about serious adverse events. … Evidence is insufficient to draw conclusions about serious adverse events. … events, nausea, dizziness, and somnolence, but serious adverse events are uncommon in randomized trials … Large increases in withdrawal due to adverse events were seen with oxcarbazepine.

70. Microsoft Word - Comp Eff 10.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - d Safety outcomes considered were overall adverse events, withdrawals due to adverse events, serious … d Safety outcomes: Overall adverse events, withdrawals due to adverse events, serious adverse events … due to adverse events) … Safety and Adverse Events Rates of serious and overall adverse events Seven studies met our inclusion … events related to the nervous system, adverse events related to the cardiovascular system, and adverse

71. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - • Small to moderate, dose-dependent increases in withdrawal due to adverse events were found with … Harms and adverse events: – What are the risks of nonopioid pharmacologic agents for harms including … overdose, misuse, dependence, withdrawals due to adverse events, and serious adverse events, and … specific adverse events? … Other adverse events of interest were not reported (cognitive effects, misuse, addiction, substance

72. Treatments for Adults with Schizophrenia: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/schizophrenia-adult_research-protocol.pdf
    September 23, 2016 - Harms Outcomes: KQ 1: § Overall adverse events (frequency of any adverse events reported in trials … events (frequency of any adverse events reported in trials) § Withdrawals due to adverse events, … events (frequency of any adverse events reported in trials) • Withdrawals due to adverse events, time … ) • Significant (major) adverse events KQ 2: • Overall adverse events (frequency of any adverse events … reported in trials) • Withdrawals due to adverse events, time to withdrawal due to adverse events

73. Update Topic Brief CER 27 NSD FINAL_SJ final (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_overview.pdf
    January 17, 2014 - mellitus, what is the comparative safety of the following treatment options in terms of the following adverse … events and side effects? … addition to updating information on the potential benefits of available treatments, conclusions regarding adverse … events should also be updated. … There have been a number of potential adverse events associated with rosiglitazone (e.g. increased

74. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    May 29, 2025 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … NR Serious adverse events: none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs … adverse events: 13% (28/215) vs. 19.4% (42/216), OR 0.64 (95% CI 0.38 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

75. Appendix-E-Table-E5 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    May 29, 2025 - Events Other Reported Outcomes Funding Source Risk of Bias 21087411 Bestard, 2011 Prospective cohort … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … NR Serious adverse events: none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs … adverse events: 13% (28/215) vs. 19.4% (42/216), OR 0.64 (95% CI 0.38 to 1.04) Withdrawals due to adverse … events: 4.65% (10/215) vs.

76. Effectiveness and Safety of Bronchial Thermoplasty in Management of Asthma: Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
    December 01, 2017 - • BT causes more adverse events (such as worsening of asthma symptoms, respiratory infections, and … • Patients treated with BT developed the following common adverse events: bronchial irritation, chest … Serious adverse events occurred more frequently in BT-treated patients than in patients receiving sham … Serious adverse events attributed to BT were infrequent, and no deaths were reported. … The risk of adverse events is higher early in treatment, while benefit is typically observed weeks to

77. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dot-plots-methods.pdf
    October 01, 2021 - events in randomized trials, Dr. … The dot plot also shows the number of adverse events in each group. … For dichotomous outcomes, the dot plots show for each outcome the pooled absolute rate of events in … events, cancer, diabetes, myalgia, and liver enzyme abnormalities. … events, serious adverse events, nausea, vomiting, constipation, somnolence, dizziness, and pruritus

78. Management of Primary Headache During Pregnancy: Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/headaches-pregnancy.pdf
    March 23, 2019 - events o Maternal  Serious maternal adverse events* • “Serious” adverse events (including those … events* o Fetal/infant  Serious fetal/infant adverse events* • “Serious” adverse events (including … events o Maternal  Serious maternal adverse events* • “Serious” adverse events (including those … events* o Fetal/infant  Serious fetal/infant adverse events* • “Serious” adverse events (including … ) due to neonatal/infant adverse events.

79. Comparative Effectiveness Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - COX-2s vs NSAIDs - tolerability Trial Withdrawals due to adverse events Total adverse events … COX-2s vs NSAIDs - tolerability Trial Withdrawals due to adverse events Total adverse events … COX-2s vs NSAIDs - tolerability Trial Withdrawals due to adverse events Total adverse events … Adverse Effects Reported Total withdrawals; withdrawals due to adverse events Tugwell 2004 Not … due to adverse events Appendix F.

80. AHRQ Evidence-based Practice Center Program Research Gaps Summary: Primary Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - Evidence is insufficient to draw conclusions about serious adverse events. … Evidence is insufficient to draw conclusions about serious adverse events. … events, nausea, dizziness, and somnolence, but serious adverse events are uncommon in randomized … Large increases in withdrawal due to adverse events were seen with oxcarbazepine. … characterization of what adverse events to expect.